Integrating the gut microbiome into therapeutic drug monitoring and model-informed precision dosing: a clinical pharmacy perspective
Interindividual variability in drug response remains a central obstacle to effective pharmacotherapy, and much of it persists after accounting for the pharmacogenomic factors that currently guide individualized treatment. Therapeutic drug monitoring (TDM) and model-informed precision dosing (MIPD) have become a mature,...